The @fda.gov has approved Breyanzi® for the treatment of adult patients with R/R #marginalZoneLymphoma who have received at least 2 prior lines of systemic therapy. From @medicalprofref.bsky.social.
https://bit.ly/3KRugOc
#MZL #lymsm
🚨 UPDATE: The @fda.gov has approved a new therapy for #marginalzonelymphoma. The approval is based on results from a phase 2 clinical trial led by Dr. Lia Palomba, a hematologist-oncologist at MSK.
Learn more: bit.ly/4iVd9Y6
#BristolMyersSquibb has taken #CARTtherapy of #bloodcancers into new territory, after getting #FDAapproval for Breyanzi as a treatment for relapsed or refractory #marginalzonelymphoma (MZL).
pharmaphorum.com/news/bmss-br...
#Lymphopoiesiscont36 #NonHodgkinsLymphoma #BurkittLymphoma #FollicularLymphoma #MantleCellLymphoma #MarginalZoneLymphoma #DiffuseLargeBCellLymphoma #PrimaryCNSLymphoma #BCellLymphoma #LymphomaAwareness #Oncology #CancerEducation #MedicalNotes #Hematology #ChromosomalTranslocation #GeneticMutations #MedicalInfographic #Histopathology #MedicalLearning #MedStudent #Pathology
#Lymphopoiesiscont36
#NonHodgkinsLymphoma #BurkittLymphoma #FollicularLymphoma #MantleCellLymphoma #MarginalZoneLymphoma #DiffuseLargeBCellLymphoma #PrimaryCNSLymphoma #BCellLymphoma #LymphomaAwareness #Oncology #CancerEducation #MedicalNotes #Hematology #ChromosomalTranslocation #GeneticMutations
#NICE #EliLilly #Omvoh #Crohnsdisease #BeOneMedicine #Brukinsa #mantlecelllymphoma #ulcerativecolitis #NICEguidance #gastroenterology #SMC #Brukinsa #relapsedMCL #refractoryMCL #Waldenstromsmacroglobulinaemia #chroniclymphocyticleukaemia #marginalzonelymphoma
pharmaphorum.com/news/nice-ba...